Agene
Company

date founded

General

About Company
Agene is a biomedical high-tech company that develops ultra-sensitive genetic testing technologies.

Industry

Sector :

Subsector :

founded date

01.01.2017

Company Type

For Profit

IPO status

Private

Description

The company focuses on using mNGS and multiplex PCR in a clinical setting to improve pathogen detection and identification, and advance precision medicine in infectious diseases. They continuously innovate and upgrade their products to meet clinical needs. Agene was acquired by Fujian Aohua Group on June 12th, 2019.
Similar Companies
1000
Bioyong Technology

Bioyong Technology

Beijing Bioyong Technology is a biotechnology company that develops clinical time-of-flight (TOF) mass spectrometry systems.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Beijing, China

Dinfectome

Dinfectome develops molecular detection tech for pathogenic microorganisms, improving liquid biopsy and precision medicine in cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

total rounds

1

total raised

$30.72M
OpGen

OpGen

OpGen is a precision medicine company that develops molecular microbiology solutions to combat infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Rockville, MD, USA

total rounds

21

total raised

$172.61M

count Of Investments

1
Microread

Microread

Microread is a company that develops detection reagents for gene testing.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Test and Measurement, Genetics

Location

Haidian District, Beijing, China

total rounds

3

total raised

$1.91M

Financials

Co-Investors

Activity

Recent News
0